Quidel Receives 510(k) Clearance for QuickVue® Influenza A+B Test, Assay Meets FDA’s Class II RIDT Requirements

World News: . []

Quidel Corporation NASDAQ QDEL a provider of rapid diagnostic testing solutions cellular-based virology assays and molecular diagnostic systems, announced today that it has received 510k clearance from the United S tates F...

More news and information about Quidel Corporation

Published By:

Business Wire: 23:45 GMT Tuesday 13th February 2018

Published: .

Search for other references to "quidel" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers